Startups
Synklino

Developer of a CMV-specific immunotoxin intended to eradicate cytomegalovirus infection.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 23,000 COMPANIES →

Summary

Seedtable Score

Score icon 67

Locations

Company Size

  • 1 - 11

Last Stage Round

Industry

Total Funding
$33.4M
Investors
Full Company Profile